Home Plexium

Plexium

In operation
-
Targeted Protein Degradation Technology Developer
Basic
Enterprise Profile

Basic Information

Plexium is a premier next-generation Targeted Protein Degradation (TPD) company. We are at the forefront in the rational design and discovery of various forms of monovalent protein degraders. The company leverages technologies from diverse physical sciences and computational disciplines to develop "molecular glues" that can alter E3 ligase substrate recognition capabilities. It utilizes DNA-encoded libraries to screen for molecular glue degraders in cell-based high-throughput assays.
Plexium, Inc.
SanDiego,California,United States of America
15~50 people
January 01, 2017
media@plexium.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Targeted Technology Protein Technology
Concept
Disease Treatment
Application Scenarios
Chemical Drug Innovative Drugs